MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-GJ-06-0000773
Skylark Pharmaceuticals Private Limited - pharma in Ankleshwar, Gujarat, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹3.11 Cr
▼ 40% YoY
Net loss · FY 2024
₹66.61 Lakh
Net margin -21.4%
EBITDA · FY 2024
-₹13.1 Lakh
EBITDA margin -4.2%
Authorised capital
₹7 Cr
Registered with MCA
Paid-up capital
₹1 Cr
Issued & subscribed
Satisfied charges
₹10.5 Cr
No open charges
Company age
21 yrs
Est. 2005
Employees · EPFO
6
Provident fund records
About Skylark Pharmaceuticals Private Limited
Data last updated:
Skylark Pharmaceuticals Private Limited is a private limited company based in Ankleshwar, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 18 July 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24230GJ2005PTC046440. Its GSTIN is 24AAJCS1663B1ZO (Gujarat).
The company has an authorised share capital of ₹7 Cr and a paid-up capital of ₹1 Cr. It is led by directors including Kamleshkumar Gaurishankar Patel and Mukesh Narbheram Chadderwala.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Plot No. 7910 GIDC Ankleshwar, Gujarat, India – 393002.
As per the financials filed for FY 2024, the company reported a revenue of ₹3.11 Cr, a decline of 40% compared to the previous year. For the same year it recorded a net loss of ₹66.61 Lakh (net margin -21.4%) and EBITDA of -₹13.1 Lakh (EBITDA margin -4.2%). Revenue has declined at a compounded annual rate (CAGR) of 36% over three years and 23% over five years.
The company has about 6 employees on its provident fund (EPFO) records.
As per MCA filings, the company has satisfied charges of ₹10.5 Cr on record. Court records list 3 cases involving the company, including 3 filed against it; 1 case is pending.
Skylark Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-06-0000773). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website skylarkpharmaceuticals.com.
Company details
CIN U24230GJ2005PTC046440
Registration Number 046440
Incorporation Date 18 July 2005
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-GJ-06-0000773
Key People
Kamleshkumar Gaurishankar Patel Director Mukesh Narbheram Chadderwala Director Prakashbhai Narbhaeram Chadderwala Director Recognitions & Rankings of Skylark Pharmaceuticals
Contact details
Skylark Pharmaceuticals Private Limited's registered office is in Ankleshwar, Gujarat. Its website is skylarkpharmaceuticals.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressPlot No. 7910 GIDC Ankleshwar, Gujarat, India – 393002
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Skylark Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Skylark Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Skylark Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Skylark Pharmaceuticals Private Limited, buy the company report.
Financials of Skylark Pharmaceuticals Private Limited
FY 2024 filings availableSkylark Pharmaceuticals Private Limited reported revenue of ₹3.11 Cr (down 40% YoY) for FY 2024.
Revenue · FY 2024
₹3.11 Cr ▼ 40%
Net loss · FY 2024
₹66.61 Lakh margin -21.4%
EBITDA · FY 2024
-₹13.1 Lakh margin -4.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 40%
3 years · compounded
▼ 36%
5 years · compounded
▼ 23%
EBITDA CAGR growth
1 year
▼ 143%
3 years · compounded
▼ 36%
5 years · compounded
▲ 30%
Revenue has declined at a compounded annual rate (CAGR) of 23% over five years, including a 40% fall in the latest year. EBITDA fell 143% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹3.11 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹13.1 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹66.61 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -4.2% | ||||
| Net Profit Margin | -21.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Skylark Pharmaceuticals Private Limited, buy the company report.
Board of directors of Skylark Pharmaceuticals Private Limited
Skylark Pharmaceuticals has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kamleshkumar Gaurishankar Patel | Director | 18 Jul 2005 | 21 Years 3 Months | Current |
| Mukesh Narbheram Chadderwala Also directs: MNC Realty Private Limited, Neelkanth Lease Finance Limited | Director | 18 Jul 2005 | 21 Years 3 Months | Current |
| Prakashbhai Narbhaeram Chadderwala Also directs: Neelkanth Lease Finance Limited | Director | 11 Apr 2013 | 13 Years 6 Months | Current |
Peer comparison
Skylark Pharmaceuticals Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Orphic Pharma (India) Limited | ₹3.12 Cr (FY 2025) | 33.0% | Vadodara, Gujarat, India | |||
| Crassula Pharmaceuticals Private Limited | ₹3.11 Cr (FY 2025) | 87.0% | Indore, Madhya Pradesh, India | |||
| Talin Remedies Private Limited | ₹3.11 Cr (FY 2025) | -9.0% | Amritsar, Punjab, India | |||
| Skylark Pharmaceuticals Private Limitedthis company | ₹3.11 Cr (FY 2024) | -₹66.61 Lakh | -21.4% | -40.0% | 6 | Ankleshwar, Gujarat, India |
| Amr Pharma India Private Limited | ₹3.11 Cr (FY 2019) | 158.0% | Chennai, Tamil Nadu, India | |||
| Shwet Biotech Private Limited | ₹3.1 Cr (FY 2021) | 10.0% | Mumbai, Maharashtra, India | |||
| Medinok Healthcare Private Limited | ₹3.1 Cr (FY 2025) | -25.0% | Puducherry, India |
To see the full peer comparison of Skylark Pharmaceuticals Private Limited, buy the company report.
Auditor
Skylark Pharmaceuticals Private Limited is audited by ARGS & ASSOCIATES for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ARGS & ASSOCIATES | FY 2024 | 104035W |
Shareholding
The shareholding of Skylark Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Skylark Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
None
Satisfied charges
₹10.5 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 29 Oct 2020 | 100387720 | Others | ₹1 Cr | Satisfied | |
| 04 Jun 2016 | 100034244 | Others | ₹1.5 Cr | Satisfied | |
| 19 Feb 2014 | 10480639 | Prime Co-Operative Bank Limited | ₹5.5 Cr | Satisfied | |
| 01 Jan 2014 | 10473923 | Prime Co-Operative Bank Limited | ₹2.5 Cr | Satisfied |
To see the full charge records of Skylark Pharmaceuticals Private Limited, buy the company report.
Total charge records: 4 View all charges
Legal cases
Skylark Pharmaceuticals Private Limited has 3 court cases on record: 3 filed against it. 1 case is pending and 2 are disposed.
Total cases
3
Filed against the company
3
Pending
1
Disposed
2
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 3 | 3 | 1 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai City Civil Court, Maharashtra | Commercial suit | Filed against the company by an individual | Pending |
| District court, Ahmedabad, Gujarat | Court case (SMST R) | Filed against the company by Rishabh Life Science Pvt Ltd., Authorised Person Nitin S. Shah | Disposed |
| District court, Vadodara, Gujarat | Court case (SMST R) | Filed against the company by an individual | Disposed |
To see the full case history of Skylark Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Skylark Pharmaceuticals Private Limited has 10 MSME Form 1 returns on record between 2019 and 2023, listing 733 overdue payments to 62 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 62)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| Akshar Pharmaceutical | |||
| an individual supplier | |||
| an individual supplier | |||
| Gujarat Marketing |
To see the full MSME payment records of Skylark Pharmaceuticals Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Skylark Pharmaceuticals Private Limited has a workforce of 6 employees on its EPFO records as of Mar 26, 2025, across 1 active EPFO establishment.
Employee count
6
Active EPFO establishments
1
Employee growth
-33.33%
GST
Skylark Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAJCS1663B1ZO | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Skylark Pharmaceuticals Private Limited, buy the company report.
Recent activity
Skylark Pharmaceuticals Private Limited has 5 board changes on record since 2005: 3 appointments and 2 cessations. The latest: Prakashbhai Narbhaeram Chadderwala ceased to be Additional Director on 30 Sep 2013.
Charges
A charge registered on 29 Oct 2020 via Charge ID 100387720 with Others was fully satisfied on 25 Nov 2024.
Charges
A charge registered on 04 Jun 2016 via Charge ID 100034244 with Others was fully satisfied on 25 Nov 2024.
Charges
A charge registered on 19 Feb 2014 via Charge ID 10480639 with Prime Co-Operative Bank Limited was fully satisfied on 25 Nov 2024.
Charges
A charge registered on 01 Jan 2014 via Charge ID 10473923 with Prime Co-Operative Bank Limited was fully satisfied on 25 Nov 2024.
AGM
Skylark Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Skylark Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad.
Charges
A charge with Others amounted to Rs. 1.00 Cr with Charge ID 100387720 was registered on 29 Oct 2020.
Charges
A charge with Others amounted to Rs. 1.50 Cr with Charge ID 100034244 was registered on 04 Jun 2016.
Charges
A charge with Prime Co-Operative Bank Limited of Rs. 2.50 Cr registered on 01 Jan 2014 with Charge ID 10473923 was modified on 08 Aug 2014.
Charges
A charge with Prime Co-Operative Bank Limited of Rs. 5.50 Cr registered on 19 Feb 2014 with Charge ID 10480639 was modified on 06 Aug 2014.
Charges
A charge with Prime Co-Operative Bank Limited amounted to Rs. 5.50 Cr with Charge ID 10480639 was registered on 19 Feb 2014.
Charges
A charge with Prime Co-Operative Bank Limited amounted to Rs. 2.50 Cr with Charge ID 10473923 was registered on 01 Jan 2014.
6 earlier events are in the company report.
Frequently asked questions
Skylark Pharmaceuticals is an active private limited company based in Ankleshwar, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 18 July 2005 (21+ years old) and is registered under CIN U24230GJ2005PTC046440.
Skylark Pharmaceuticals has 3 current directors:
- Kamleshkumar Gaurishankar Patel - Director
- Mukesh Narbheram Chadderwala - Director
- Prakashbhai Narbhaeram Chadderwala - Director
The latest financial statements of Skylark Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Skylark Pharmaceuticals is 24AAJCS1663B1ZO, registered in Gujarat.
The CIN (Corporate Identification Number) of Skylark Pharmaceuticals is U24230GJ2005PTC046440. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Skylark Pharmaceuticals has 3 court cases on record: 3 filed against it. 1 is pending.
Skylark Pharmaceuticals was incorporated on 18 July 2005, making it 21+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Skylark Pharmaceuticals by revenue are Orphic Pharma (India) Limited, Crassula Pharmaceuticals Private Limited, Talin Remedies Private Limited, Amr Pharma India Private Limited, Shwet Biotech Private Limited and 1 more, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Prakashbhai Narbhaeram Chadderwala ceased to be Additional Director on 30 Sep 2013. Prakashbhai Narbhaeram Chadderwala was appointed as Director on 11 Apr 2013. Kapilaben Narbheram Chadderwala ceased to be Director on 15 May 2009. Skylark Pharmaceuticals has 5 board changes on record in total.
Yes, Skylark Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-GJ-06-0000773).
Skylark Pharmaceuticals has 10 MSME Form 1 returns on record between 2019 and 2023, listing 733 overdue payments to 62 micro and small suppliers. The latest return was filed on 27 Aug 2023.
Skylark Pharmaceuticals can be reached through the website skylarkpharmaceuticals.com. Its registered office is in Ankleshwar, Gujarat, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages